Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul;1(2):51-4.
doi: 10.1159/000338637.

European thyroid association guidelines on L-t4 + L-t3 combination for hypothyroidism: a weary step in the right direction

Affiliations

European thyroid association guidelines on L-t4 + L-t3 combination for hypothyroidism: a weary step in the right direction

Petros Perros. Eur Thyroid J. 2012 Jul.
No abstract available

PubMed Disclaimer

References

    1. Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MPJ. 2012 ETA Guidelines: the use of L-T4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J. 2012;1:55–71. - PMC - PubMed
    1. Bunevicius R, Kazanavicius G, Zalinkevi-cius R, Prange AJ., Jr Effects of thyroxine as compared with thyroxine plus triiodothyro-nine in patients with hypothyroidism. N Engl J Med. 1999;340:424–429. - PubMed
    1. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on ‘adequate’ doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 2002;57:577–585. - PubMed
    1. Clyde PW, Harari AE, Getka EJ, Shakir KM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in pri-mary hypothyroidism: a randomized con-trolled trial. JAMA. 2003;290:2952–2958. - PubMed
    1. Sawka AM, Gerstein HC, Marriott MJ, Mac-Queen GM, Joffe RT. Does a combination regimen of thyroxine (T4) and 3, 5, 3*prime;-triiodothyronine improve depressive symp-toms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocri-nol Metab. 2003;88:4551–4555. - PubMed